Skip to main content
. 2021 Mar;22(3):971–976. doi: 10.31557/APJCP.2021.22.3.971

Table 3.

Cervical Cancer Screening Examination Preferences (n=118)

Measure n (%)
Gender preference for provider
Male 1 (0.9)
Female 100 (84.8)
No preference 17 (14.4)
Collection type preference for HPV DNA test
Self-sampling 70 (59.3)
Clinician-sampling 33 (28.0)
No preference 15 (12.7)
Test with self-sampling again (n=117)
No 0 (0%)
Yes 117 (100%)
Recommend self-sampling to a friend
No 0 (0%)
Yes 118 (100%)

*Range from 1 to 5, 1, least favorable; 5, most favorable